Bill C-368 could significantly impact Canada’s natural health product industry and your ability to access to these products.
In our latest video, we delve into the ongoing debate over natural health product regulations. On May 22, the House of Commons resumed the second reading of Bill C-368, aiming to amend the Food and Drugs Act by repealing sections 500-504 of Bill C-47. These sections controversially moved natural health products into the same regulatory category as pharmaceutical drugs, a shift that has negatively impacted the industry.
Catch the highlights of the debate in our 5-minute video that explores key moments from Bill C-368’s second reading.
